Lactated Ringers (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the Lactated Ringers drug offered from Baxter Healthcare Corporation. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
| NON-PROPRIETARY NAME: | sodium chloride, sodium lactate, potassium chloride, calcium chloride |
| SUBSTANCE NAME: | SODIUM CHLORIDE; SODIUM LACTATE; POTASSIUM CHLORIDE; CALCIUM CHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient] |
| ROUTE: | IRRIGATION |
| DOSAGE FORM: | IRRIGANT |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1982-02-19 |
| END MARKETING DATE: | 0000-00-00 |
Lactated Ringers HUMAN PRESCRIPTION DRUG Details:
| Item Description | Lactated Ringers from Baxter Healthcare Corporation |
| LABELER NAME: | Baxter Healthcare Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 600; 310; 30; 20(mg/100mL; mg/100mL; mg/100mL; mg/100mL) |
| START MARKETING DATE: | 1982-02-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0338-0114_f09f80bf-2f8b-4420-865d-aec2d5e5cd4d |
| PRODUCT NDC: | 0338-0114 |
| APPLICATION NUMBER: | NDA018494 |
Other SODIUM CHLORIDE; SODIUM LACTATE; POTASSIUM CHLORIDE; CALCIUM CHLORIDE Pharmaceutical Manufacturers / Labelers:
